nivolumab,hyaluronidase,RCC,urothelial

Mashup Score: 1

FDA Approves Nivolumab, Hyaluronidase-nvhy for Subcutaneous Injection | GU Oncology Now - 20 hour(s) ago

The FDA has approved nivo for subcutaneous injection for all solid tumors for which nivo is indicated as a monotherapy.

Source: guoncologynow.com

Categories: General Medicine News, Onc News and Journals

Tweet Tweets with this article
- GUOncologyNow
  
  ❗️ The @US_FDA has approved subcutaneous #nivolumab and #hyaluronidase-nvhy for solid tumors for which nivolumab is indicated as a monotherapy. 🔎 The combination is indicated for #RCC, #urothelial carcinoma, and more: https://t.co/bdeA5tXgsp